SANGAMO THERAPEUTICS, INC. (SGMOQ) Operating cash flow 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$97.2MFY2025 · since FY2016: -$65.9M → -$97.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.2M | -44.8% |
| FY2024 | -$67.1M | +70.1% |
| FY2023 | -$224.8M | -0.5% |
| FY2022 | -$223.6M | +4.1% |
| FY2021 | -$233.3M | -237.3% |
| FY2020 | $169.9M | +217.6% |
| FY2019 | -$144.4M | -495.1% |
| FY2018 | $36.5M | +227.0% |
| FY2017 | $11.2M | +117.0% |
| FY2016 | -$65.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice